_256_384.jpg)
Medical Device | November 01, 2021
Holborn Wells and SpeedBio India forms JV to manufacture in vitro diagnostics
Both parties are expected to invest a total of US $ 1 million to establish the brand
Both parties are expected to invest a total of US $ 1 million to establish the brand
New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
Redbiotec has a right to royalties on Eurocine Vaccines´ net sales of an approved HSV-2 vaccine, should such sales arise.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
